News & Media

Take a closer look at what we’re doing across Teva worldwide

Press releases

Teva Reports Fourth Quarter and Full Year 2020 Financial Results

Teva Reports Fourth Quarter and Full Year 2020 Financial Results

Teva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal...

Teva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal Ring

Teva Sets Ambitious Long-Term Environmental Goals As Part of Renewed ESG Strategy

Teva Sets Ambitious Long-Term Environmental Goals As Part of Renewed ESG Strategy

Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Gui...

Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance

Teva to Present at the 39th Annual J.P. Morgan Healthcare Conference

Teva to Present at the 39th Annual J.P. Morgan Healthcare Conference

Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Rele...

Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release S

Teva Reports Third Quarter 2020 Financial Results

Teva Reports Third Quarter 2020 Financial Results

Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride Exte...

Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP 500 mg and 750 mg due to detection of N-Nitrosodimethylamine (NDMA)

Teva Presented New Data at the European Academy of Neurology Congress Evaluating the AJOVY® (fremane...

Teva Presented New Data at the European Academy of Neurology Congress Evaluating the AJOVY® (fremanezumab

Teva to Present New AJOVY® (fremanezumab) Analyses and Latest COPAXONE® Data (glatiramer acetate inj...

Teva to Present New AJOVY® (fremanezumab) Analyses and Latest COPAXONE® Data (glatiramer acetate injectio
See all press releases
Previous
Next

Top Stories

Read the latest Teva news

Black History Month

Black History Month

Improving access to medicines for 4000 children with cancer in Malawi

Improving access to medicines for 4000 children with cancer in Malawi

How do I…put patient safety first?

How do I…put patient safety first?

How do I…get dressed for work?

How do I…get dressed for work?

Behind the Numbers – Who Cares for the Carers?

Behind the Numbers – Who Cares for the Carers?

Black History Month Spotlight

Black History Month Spotlight

Teva USA Earns Perfect Score In 2021 Corporate Equality Index

Teva USA Earns Perfect Score In 2021 Corporate Equality Index

Teva sets ambitious long-term environmental goals

Teva sets ambitious long-term environmental goals

‘It has made a real difference’: Increasing access to medicines in Haiti

‘It has made a real difference’: Increasing access to medicines in Haiti

‘Biosimilars are advancing more treatment options for patients’

‘Biosimilars are advancing more treatment options for patients’
View all stories

Media Resources

Intended for use by media professionals; may be downloaded for non-commercial use 

Media Inquiries

Contact our corporate communications.

Learn more Media Inquiries

Media Kit

Files and resources for media use only

Download Teva Media Kit Media Kit

Financial Reports

View Teva financial news on our global website.

Learn more Financial Reports

Connect with us

Teva Social Media Guidelines.

Learn more Connect with us